Terms: = Leukemia AND GOPC, FIG, 57120, ENSG00000047932, GOPC1, Q9HD26, CAL, dJ94G16_2 PIST AND Prognosis
8 results:
1. Recurrent 8q24 rearrangement in blastic plasmacytoid dendritic cell neoplasm: association with immunoblastoid cytomorphology, MYC expression, and drug response.
Sakamoto K; Katayama R; Asaka R; Sakata S; Baba S; Nakasone H; Koike S; Tsuyama N; Dobashi A; Sasaki M; Ichinohasama R; Takakuwa E; Yamazaki R; Takizawa J; Maeda T; Narita M; Izutsu K; Kanda Y; Ohshima K; Takeuchi K
Leukemia; 2018 Dec; 32(12):2590-2603. PubMed ID: 29795241
[TBL] [Abstract] [Full Text] [Related]
2. Idelalisib: First-in-Class PI3K Delta Inhibitor for the Treatment of Chronic Lymphocytic leukemia, Small Lymphocytic leukemia, and Follicular Lymphoma.
Yang Q; Modi P; Newcomb T; Quéva C; Gandhi V
Clin Cancer Res; 2015 Apr; 21(7):1537-42. PubMed ID: 25670221
[TBL] [Abstract] [Full Text] [Related]
3. Prognostic significance of FLT3 internal tandem duplication, nucleophosmin 1, and CEBPA gene mutations for acute myeloid leukemia patients with normal karyotype and younger than 60 years: a systematic review and meta-analysis.
Port M; Böttcher M; Thol F; Ganser A; Schlenk R; Wasem J; Neumann A; Pouryamout L
Ann Hematol; 2014 Aug; 93(8):1279-86. PubMed ID: 24801015
[TBL] [Abstract] [Full Text] [Related]
4. Molecular profiling of blastic plasmacytoid dendritic cell neoplasm reveals a unique pattern and suggests selective sensitivity to NF-kB pathway inhibition.
Sapienza MR; Fuligni F; Agostinelli C; Tripodo C; Righi S; Laginestra MA; Pileri A; Mancini M; Rossi M; Ricci F; Gazzola A; Melle F; Mannu C; Ulbar F; Arpinati M; Paulli M; Maeda T; Gibellini D; Pagano L; Pimpinelli N; Santucci M; Cerroni L; Croce CM; Facchetti F; Piccaluga PP; Pileri SA;
Leukemia; 2014 Aug; 28(8):1606-16. PubMed ID: 24504027
[TBL] [Abstract] [Full Text] [Related]
5. Mantle cell lymphoma: a clinically heterogeneous disease in need of tailored approaches.
Shah BD; Martin P; Sotomayor EM
Cancer Control; 2012 Jul; 19(3):227-35. PubMed ID: 22710898
[TBL] [Abstract] [Full Text] [Related]
6. Hairy cell leukemia: towards a curative strategy.
Gidron A; Tallman MS
Hematol Oncol Clin North Am; 2006 Oct; 20(5):1153-62. PubMed ID: 16990114
[TBL] [Abstract] [Full Text] [Related]
7. Plasma cell myeloma--new biological insights and advances in therapy.
Barlogie B; Epstein J; Selvanayagam P; Alexanian R
Blood; 1989 Mar; 73(4):865-79. PubMed ID: 2465790
[TBL] [Abstract] [Full Text] [Related]
8. Methotrexate infusions in poor prognosis acute lymphoblastic leukemia: II. High-dose methotrexate (HDM) in acute lymphoblastic leukemia in childhood: a pilot study from April 1981.
Moe PJ; Wesenberg F; Kolmannskog S
Med Pediatr Oncol; 1986; 14(3):189-90. PubMed ID: 3462466
[TBL] [Abstract] [Full Text] [Related]
